Macrogenics reported $392.16M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Biogen BIIB:US $ 23806.7M 663.7M
Bristol Myers Squibb BMY:US $ 110893M 96M
Cerulean Pharma CERU:US $ 48.81M 33.99M
Daiichi Sankyo 4568:JP Y 2110729M 48259M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Eli Lilly And LLY:US $ 48187M 378M
Epizyme EPZM:US $ 332.27M 20.28M
Genmab GEN:DC DK 23985M 1502M
Geron GERN:US $ 229.1M 23.08M
Gilead Sciences GILD:US $ 67098M 886M
Immunogen IMGN:US $ 296.8M 4.64M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Macrogenics MGNX:US $ 392.16M 33.75M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Puma Biotechnology PBYI:US $ 226.29M 33.71M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Xencor XNCR:US $ 697.26M 1.66M